Not a terrible point but it's worth considering that this was a 70-year-old drug. It's not like Shkreli put the money into the research in the first place, and he certainly profited personally.
(Not sure why anyone owns the "rights" to a drug that old in the first place..)
Comments
Daraprim is actually much cheaper than lots of other rare disease drugs.
How are you supposed to make money making rare disease drugs if you sell them cheaply?
Not a terrible point but it's worth considering that this was a 70-year-old drug. It's not like Shkreli put the money into the research in the first place, and he certainly profited personally.
(Not sure why anyone owns the "rights" to a drug that old in the first place..)